XFOR filings
Corporate insider profile
David Kirske Filing Activity
Latest reported as Chief Financial Officer of X4 Pharmaceuticals, Inc (XFOR).
- Purchase filings
- 0
- Reported companies
- 1
- Net open-market value
- -$72,820.36
- Latest transaction
- May 12, 2026
Affiliated corporations
Reported company relationships
Transaction history
